[Current use of anti-hemostatics in ischemic cardiopathy].
Antihemostatic drugs are widely used in the treatment and prevention of ischemic heart disease. Fibrinolytic agents are prescribed in the early phase of acute myocardial infarction, to reduce its size and improve survival. Their use in unstable angina is still controversial. Anticoagulants have substantial benefit in myocardial infarction, unstable angina and primary prevention of coronary disease. Finally, antiplatelet agents are used in stable and unstable angina, myocardial infarction and high risk patients.
Bolao
I G
IG
Departmento de Cardiología y Cirugía Cardiovascular, Facultad de Medicina, Universidad de Navarra, Pamplona.
Alegría
E
E
Iglesias
I
I
Velasco
S
S
Fidalgo
M L
ML
Gómez
J A
JA
Huelmos
A
A
D000789:Angina, Unstable / Q000188:drug therapy; D000800:Angioplasty, Balloon; D000925:Anticoagulants / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy; D017202:Myocardial Ischemia / Q000188:drug therapy* / Q000517:prevention & control / Q000601:surgery; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors
Empleo actual de los antihemostáticos en la cardiopatía isquémica.